LON:GSK - GlaxoSmithKline Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started GBX 1,562.40 -3.60 (-0.23 %) (As of 03/22/2019 09:05 AM ET)Previous CloseGBX 1,566Today's RangeGBX 1,552.40 - GBX 1,57052-Week RangeGBX 1,269.80 - GBX 1,648.80Volume3.20 million shsAverage Volume9.12 million shsMarket Capitalization£76.87 billionP/E Ratio21.43Dividend Yield6.10%BetaN/A ProfileDiscussionAnalyst RatingsChartDividendEarningsInsider TradesHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings GlaxoSmithKline (LON:GSK) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.18 Wall Street analysts have issued ratings and price targets for GlaxoSmithKline in the last 12 months. Their average twelve-month price target is GBX 1,518.15The high price target for GSK is GBX 1,900 and the low price target for GSK is GBX 41.74. There are currently 2 sell ratings, 11 hold ratings and 5 buy ratings for the stock, resulting in a consensus rating of "Hold."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: HoldHoldHoldHoldConsensus Rating Score: 188.8.131.522.36Ratings Breakdown: 2 Sell Rating(s)11 Hold Rating(s)5 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)10 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)10 Hold Rating(s)8 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)12 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: GBX 1,518.15GBX 1,520.93GBX 1,530.34GBX 1,522.35GlaxoSmithKline (LON:GSK) Consensus Price Target History GlaxoSmithKline (LON:GSK) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetDetails3/20/2019Shore CapitalReiterated RatingHold3/20/2019Liberum CapitalReiterated RatingHold3/19/2019UBS GroupReiterated RatingNeutral3/14/2019Jefferies Financial GroupReiterated RatingBuy3/11/2019BarclaysReiterated RatingEqual weight2/12/2019Deutsche BankSet Price TargetNeutralGBX 1,5202/7/2019Kepler Capital MarketsSet Price TargetNeutralGBX 1,4402/7/2019Credit Suisse GroupSet Price TargetNeutralGBX 1,6002/7/2019HSBCBoost Price TargetBuyGBX 1,820 ➝ GBX 1,8602/6/2019Goldman Sachs GroupSet Price TargetBuyGBX 1,90012/14/2018Morgan StanleySet Price TargetSellGBX 1,46012/14/2018Bank of AmericaSet Price TargetNeutralGBX 1,63512/4/2018CfraSet Price TargetNeutralGBX 1,62011/23/2018JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,6009/11/2018BNP ParibasSet Price TargetBuyGBX 1,7509/10/2018Societe GeneraleSet Price TargetSellGBX 1,0008/23/2018Berenberg BankReiterated RatingBuyGBX 1,7907/26/2018CitigroupReiterated RatingNeutral2/8/2018Beaufort SecuritiesUpgradeBuyGBX 1,450 ➝ GBX 1,5002/7/2018Sanford C. BernsteinSet Price TargetNeutralGBX 1,58011/6/2017InvestecDowngradeHoldGBX 1,800 ➝ GBX 1,39010/26/2017S&P GlobalSet Price TargetNeutralGBX 1,5009/19/2017Bryan, Garnier & CoReiterated RatingNeutralGBX 1,710(Data available from 3/22/2017 forward) This page was last updated on 3/22/2019 by MarketBeat.com StaffFeatured Article: What is the Coverage Ratio?